AMAERO INC CDI (3DA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

3DA

3DA - AMAERO INC CDI

Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: -0.94
Index: ALL-ORDS

Amaero manufactures titanium and refractory alloy metal powders in the US for additive and advanced manufacturing, serving defence, aerospace, space, medical and industrial applications.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.17

22 Oct
2026

-0.020

OPEN

$0.18

-10.53%

HIGH

$0.18

991,243

LOW

$0.17

OTHER COMPANIES IN THE SAME SECTOR
ALQ . AVD . BOL . BSA . BWN . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . FDC . FLC . IPG . LBL . MAD . MPW . MYG . PPK . RWL . SDV . SHA . SND . SSM . SXE . SYL . TEA . VBC . VEE . VNT . VYS .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx-0.1
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx18.1 M
Book Value Per Share xxxxxxxxxxxxxxx0.2
Net Operating Cash Flow xxxxxxxxxxxxxxx-35.4 M
Net Profit Margin xxxxxxxxxxxxxxx-201.23 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-59.17 %
Return on Invested Capital xxxxxxxxxxxxxxx-38.56 %
Return on Assets xxxxxxxxxxxxxxx-32.98 %
Return on Equity xxxxxxxxxxxxxxx-59.17 %
Return on Total Capital xxxxxxxxxxxxxxx-36.53 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-66.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx44 M
Total Debt xxxxxxxxxxxxxxx44 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx19 M
Price To Book Value xxxxxxxxxxxxxxx138.12

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx31.3 M
Capex % of Sales xxxxxxxxxxxxxxx172.73 %
Cost of Goods Sold xxxxxxxxxxxxxxx26 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx27 M
Research & Development xxxxxxxxxxxxxxx1 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Research as a Service (RaaS)

21/10/2026

-1

No Rating

-10.53%

Research as a Service (RaaS) lifts its FY27 revenue forecast for advanced materials manufacturer Amaero by 20% to $31.2m, supported by a $23.1m opening order backlog and anticipated contract wins. Its forecast net loss narrows by 11% to -$20.8m.

The researcher views Amaero's Nasdaq debut positively, with the US$20m capital raising accompanied by stronger trading volumes and a higher share price.

Further commercial agreements across defence, aerospace and medical markets, alongside improving margins, are identified as potential catalysts for a re-rating.

RaaS retains its valuation of 68c per CDI, implying around 267% upside to the report's prevailing price. The researcher forecasts near EBITDA break-even in FY28 and net profit break-even in FY29, with production delays and execution risks remaining key uncertainties.

Research as a Service does not carry any ratings or targets. Investors can draw conclusions from valuations and commentary.

FORECAST
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -2.00 cents.
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -1.00 cents.

3DA STOCK CHART